[Skip to content]

You are here:   Home  »  About us  »  Departments and services  »  Breast Care  »  Information for patients  »  BIA-ALCL


The UK Medicines and Healthcare products Regulatory Agency (MHRA) published a statement regarding breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) in July 2017. This is a condition which can arise in people who have breast implants, whether for breast reconstruction following mastectomy or for cosmetic breast augmentation. The condition is rare and as it has only been recognised in the past few years, work is currently being carried out to learn more about it.

The MHRA advise patients that:

"The most common symptom for ALCL in women with breast implants is a seroma (a collection of fluid) that forms around the breast implant six months or more after the breast implant surgery.

Most cases have happened years after surgery. Very rarely it has been found when a lump develops next to the implant or within the tough fibrous tissue building up around the implant (known as capsular contracture).

ALCL is very rare but it is important healthcare professionals and women who have implants know about it. If you develop a seroma, a breast lump or swelling around your implant more than six months after having the breast implant (regardless of how many years later), you should seek advice from your surgeon or clinic.

If the surgeon or clinic which did the original implant operation is no longer available then the patient should see their GP for referral to another surgeon.

As with any implant it is important anyone undergoing breast implant surgery discusses the risks and benefits with their surgeon.

If you have had an issue with a breast implant you should report it via the Yellow Card Scheme so we can investigate further."